Zacks Investment Research on MSN
Here's why you should retain Masimo stock in your portfolio now
Masimo Corporation MASI is well-poised for growth in the coming quarters, courtesy of its strong underlying demand for ...
The use of pulse oximetry improves the early detection of hypoxaemia, generally considered a major risk factor for child mortality, especially in settings where severe illness may otherwise go ...
rDepartment of Pharmacy, Makerere University School of Health Sciences, Kampala, Uganda The COVID-19 pandemic revealed long-standing deficits in access to lifesaving medical oxygen, especially in ...
Please provide your email address to receive an email when new articles are posted on . The Connected Wearables platform uses data from an FDA-cleared wearable proximal finger-mounted pulse oximeter.
Zynex (Nasdaq:NYXI) announced today that it submitted its NiCO non-invasive co-oximeter device for FDA 510(k) clearance. The Englewood, Colorado–based company said its submission marks a milestone in ...
IRVINE, Calif.--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) announced today FDA clearance of MightySat ® Medical, making it the first and only FDA-cleared medical fingertip pulse oximeter available ...
Background: Hypoxemia, characterized by low levels of oxygen in the blood, is a potentially fatal condition that is commonly found in pediatric and neonatal conditions that drive childhood mortality ...
In a letter to the U.S. Food and Drug Administration, the Cystic Fibrosis Foundation responded to the agency’s draft guidance entitled “Pulse Oximeters for Medical Purposes — Non-Clinical and Clinical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results